Medine.co.uk

Temgesic 200 Microgram Sublingual Tablets

cn

00

cn

3    3

3    3

3

3


Pharmacode Reads This Way


PACKAGE LEAFLETT INFORMATION FORTHEUSEfi

Temgesic® 200 microgram

Buprenorphine hydrochloride

||lNDIVIOR



Read all of this leaflet carefully before you start

taking this medicine.

-    Keep this leaflet You may need to read it again.

-    If you have any further questions, ask your doctor or pharmacist.

-    This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.

-    If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.


~' In this leaflet:

! 1. What Temgesic Sublingual Tablets are and | what they are used for . 2. Before you take Temgesic Sublingual M Tablets

4 3. How to take Temgesic Sublingual Tablets ■4. Possible side effects □ 5. Howto store Temgesic Sublingual Tablets "l 6. Further information


1. WHATTEMGESIC SUBLINGUALTABLETS ARE ANDWHATTHEYARE USED FOR


Temgesic Sublingual Tablets are strong pain killers that help lessen moderate or severe pain.


2. BEFOREYOUTAKETEMGESIC SUBLINGUAL TABLETS

Do not take Temgesic

If you are allergic (hypersensitive) to buprenorphine, to any of the other ingredients of Temgesic Sublingual Tablets (see section 6 'Further Information') or to other opiates (drugs which are morphine - like in their action).

Take special care with Temgesic Sublingual Tablets

Before starting treatment with Temgesic, contact your doctor if you:

•    Are or have ever been addicted to medicines or substances;

•    Have problems with your liver;

•    Have breathing problems or are taking medicines which may make your breathing slower or weaker.

Athletes must be aware that this medicine may cause a positive reaction to 'anti-doping' tests. Taking other medicines Temgesic should not be taken with:

•    Medicines containing gestodene (a hormone);

•    Antibiotic medicines (troleandomycin, rifampicin);

•    Medicines to treat fungal infections (ketoconazole);

•    Medicines for depression (norfluoxetine);

•    Medicines for HIV infection (protease inhibitors: ritonavir, indinavir, saquinavir);

•    Medicines for epilespsy (carbamazepine, phenytoin, phenobarbital);

•    Other opioid medicines.

In particular, you should also tell your doctor if you are taking:

•    Medicines used to treat depression known as monoamine oxidase inhibitors (examples include tranylcypromide, phenelzine);

•    Medicines to help you sleep (for example tranquilisers, hypnotics or sedatives).

You should visit your doctor regularly whilst you are taking these medicines at the same time as Temgesic.

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

Taking Temgesic Sublingual Tablets with food and drink

Do not drink alcohol while you are taking this medicine as it may make you feel drowsy.


Pregnancy ancTbreast-feeding

You should tell your doctor if you are pregnant or ; breast-feeding before taking Temgesic.

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

If you feel drowsy while taking these tablets do not ! drive or use machines.    j

The medicine can affect your ability to drive as it | may make you sleepy or dizzy.

•    Do not drive while taking this medicine until you i

know how it affects you.    |

   It is an offence to drive if this medicine affects your ability to drive.

•    However, you would not be committing an !

offence if:    ]

o The medicine has been prescribed to treat a

medical or dental problem and    !

o You have taken it according to the instructions j given by the prescriber or in the information provided with the medicine and    !

o It was not affecting your ability to drive safely ;

Talk to your doctor or pharmacist if you are not sure! whether it is safe for you to drive while taking this | medicine.

The new driving offence concerning driving after drugs have been taken applies in Great Britain. There is further information for patients who are | intending to drive in Great Britain available at: https://www.gov. u k/d rug-d rivi ng-law

Important information about some of the ingredients of Temgesic Sublingual Tablets

Temgesic tablets contain lactose (a type of of ; sugar). If you have been told by your doctor that you have an intolerance to some sugars, contact ! your doctor before taking this medicinal product. |

3.    HOWTOTAKETEMGESIC SUBLINGUALTABLETS j

Always take Temgesic exactly as your doctor has | told you. You should check with your doctor or pharmacist if you are not sure. Do not take more tablets than your doctor has told you to.

Adults and children over 12 years of age

The usual dose is one or two 200 microgram tablets; every six to eight hours, or as required. Place the tablet under your tongue and let it dissolve.

Do not swallow or chew the tablet.

Children between 6 years and 12 years of age The dose depends on their weight and your doctor ! will tell you the correct dose for your child.    j

This product will not be given to infants and children under 6 years of age.

If you take more Temgesic Sublingual Tablets than! you should

If you accidentally take too many tablets you must i get medical help at once. Take any remaining I medication, the carton and the leaflet with you j when seeking medical attention.

If you forget to take Temgesic Sublingual Tablets ; If you forget to take a dose, take it as soon as you remember unless it is time for your next dose. Do j not take a double dose to make up for a missed ; dose.

4.    POSSIBLE SIDE EFFECTS

Like all medicines, Temgesic can cause side effects, ' although not everybody gets them.    I

Tell your doctor immediately if you experience any! of the following symptoms after taking this    |

medicine. Although they are rare, these symptoms ; can be serious

•    if you get any sudden wheeziness, difficulty    j

breathing, swelling of the eyelids, face or lips, ; rash or itching especially those covering your whole body. These may be signs of an allergic | reaction.    j

•    if you start to breathe more slowly or weakly than'

expected (respiratory depression)    |

•    if you start to feel faint, as this may be a sign of j low blood pressure.


INDDQ174


◄-►

170 mm


▲ ~T


300 mm



Other side effects that may occur with Temgesic are:

t Effects on your stomach or intestine: feeling sick,

| being sick.

p Effects on your nervous system: dizziness,

| hallucinations (sensing things that are not real),

| drowsiness, headaches, sweating, p Effects on your bladder: difficulty in urinating, t Effects on your eyes: blurred vision.

Side effects that may occur when buprenorphine is jused as substitution treatment are fever, diarrhoea, loss of appetite, dark urine, yellowing of the eyes dnd skin, difficulty with balance and walking, tremor £nd impaired speech.

|lf any of the side effects get serious, or if you notice ;any side effects not listed in this leaflet, please tell your doctor or pharmacist.

fc. HOWTO STORE TEMGESIC SUBLINGUAL I TABLETS

Keep out of the reach and sight of children.

^The tablets should be stored below 30°C in the Original package.

iDo not take Temgesic tablets after the expiry date yvhich is stated on the pack (EXP month/year). The expiry date refers to the last day of that month.

[Medicine should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These [measures will help to protect the environment.

p. FURTHER INFORMATION

VVhat Temgesic Sublingual Tablets contain

The active substance is buprenorphine [hydrochloride.

The other ingredients are lactose, mannitol, maize starch, povidone K30, citric acid anhydrous, magnesium stearate, sodium citrate, purified water £nd ethanol (96%).

What Temgesic Sublingual Tablets look like and Contents of the pack

Temgesic tablets are round white tablets, marked with an L on one side.

^The tablets come in cartons containing five strips of !l0 tablets each, a total of 50 tablets.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

llndivior UK Limited

|103-105 Bath Road

Slough

[Berkshire

$L1 3UH

Manufacturer:

jReckitt Benckiser Healthcare (UK) Limited Dansom Lane !Hull,HU8 7DS

;uk.

This leaflet was last revised in July 2015


3M4.8JS


CUSTOMER 11MFO: Minimum Point Size = 9.00pt